The division of Pulmonary, Allergy & Critical Care Medicines provides exceptional clinical care, promotes novel scientific discovery, and provides outstanding educational training.

We serve patients with lung disease, sleep disorders, and critical illness; we lead investigative efforts that inform and innovate new diagnostic and therapeutic approaches to patient care; and we train the next generation of physician-scientists and clinician-educators.

We have been consistently ranked among the top programs in the nation for Respiratory Disease by US News and World Report, and our faculty members are repeatedly named among the Best Doctors in America. Our investigative programs are designed for bench-to-bedside and bedside-to-bench translation.

Our clinical research programs participate in a number of national and international research networks including the NIH-funded COPD and Pulmonary Fibrosis Networks, and the Cystic Fibrosis Foundation's Therapeutics Development Network. Through our partnerships with Southern Research Institute, the Center for Clinical Translational Science has facilitated drug discovery and development in cystic fibrosis, COPD, and idiopathic pulmonary fibrosis. Additionally, an NIH T32 Training Program in Lung Biology and Translational Medicine capitalizes on the interdisciplinary and interactive environment at UAB.

While we are indeed very proud of our clinical, research and educational achievements, our most valuable asset is an extraordinary group of professionals who are fully committed to the highest possible standards in medicine. At UAB, we strive to create a culture in which our tripartite mission - clinical care, research, and education - is well integrated. This will allow us to more effectively translate basic discoveries from our research laboratories into the clinic, while training leaders in our discipline for the future.